Company: CERO
Filing Date: 2025-11-17
Form Type: PRE 14A
Source: 0001213900-25-111175
Chunk: 50

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-11-17
Form: PRE 14A
Chunk 50
---
 Series E Convertible Preferred Stock, as amended from time to time (the “Series E Certificate of Designations” and, together with the Series A Certificate of Designations, Series B Certificate of Designations, Series C Certificate of Designations and Series D Certificate of Designations, the “Certificates of Designations”) in their entirety for a complete description of the rights and preferences of the Company’s securities. General We are authorized to issue up to 1,000,000,000shares of Common Stock, $0.0001 par value per share (“Common Stock”), and 10,000,000shares of preferred stock, par value $0.0001 per share (the “Preferred Stock”). As of November12, 2025, the Company currently has outstanding: (i) 20,802,671shares of Common Stock, (ii) 1,429shares of Series A Preferred Stock with a conversion value of approximately $1.4 million, convertible into shares of Common Stock at a conversion rate of the stated value thereof divided by a current effective conversion price of $0.05 per share; (iii) no shares of Series B Preferred Stock; (iv) 7shares of Series C Preferred Stock with a conversion value of $7,000, convertible into shares of Common Stock at a conversion rate of the stated value thereof divided by a conversion price of $0.05 per share; (v) Series A Warrants to purchase 306shares of Common Stock at an exercise price of $2,780.00 per share; (vi) Series C Warrants to purchase 4,088shares of Common Stock at an exercise price of $0.80 per share; (vii) December 2024 and January 2025 Common Warrants to purchase an aggregate of 12,396shares of Common Stock at an exercise price ranging from $112.20 to $116.40 per share, (viii) February 2025 Common Warrants to purchase an aggregate of 127,551shares of Common Stock at an exercise price of $39.20 per share, (ix) February 2025 Pre -FundedWarrants to purchase an aggregate of 10,787shares of Common Stock at an exercise price of $0.002 per share, (x) Public Warrants and Private Placement Warrants to purchase an aggregate of 4,596shares of Common Stock at an exercise price of $23,000.00 per share, (xi) 5,460shares of